Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Aug 24 EFFECT Notice of effectiveness
- 9 Aug 24 424B3 Prospectus supplement
- 9 Aug 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Aug 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Aug 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
14 Jun 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Nov 23 S-4 Registration of securities issued in business combination transactions
LIMN similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Amendment No. 1 to Form S-4 of Iris Acquisition Corp of our report dated May 13, 2024 (which includes an explanatory paragraph relating to Liminatus Pharma, LLC’s ability to continue as a going concern) relating to the financial statements of Liminatus Pharma, LLC appearing in the Prospectus, which is a part of this Registration Statement.
We also consent to the reference to our Firm under the heading “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
Whippany, New Jersey
June 14, 2024